North American Next Generation Diagnostics Entrepreneurial Company / Ramot / Tel Aviv University Ltd. / Rosetta Genomics Ltd. / /
Country
United States / Israel / /
Currency
ILS / /
Event
FDA Phase / Business Partnership / /
Facility
University Joint Development / Tel Aviv University / University Ramot / /
IndustryTerm
nano-carrier / platform technologies / technology / microRNA technology / cancer therapeutics / mimetic technology / nano-carrier system / microRNA-based diagnostic testing services / microRNA-based diagnostic tools / through distributors / cancer testing services / technology transfer / /
MedicalCondition
tumor / benign oncocytoma / cancer / primary and metastatic cancer / clear cell renal cell carcinoma / Mesothelioma / lung cancer / common kidney tumors / Treat Cancer / cardiovascular diseases / primary tumor / /
MedicalTreatment
cancer therapeutics / /
Organization
Sackler School of Medicine / Ministry of Economics / Department of Physiology and Pharmacology / Israel’s office of the Chief Scientist PRINCETON / Tel Aviv University / /
Person
Sharon Kredo-Russo / Ronit Satchi-Fainaro / Kenneth A. Berlin / Tamar Raz / / /
Position
Chief Scientist / President / Director / R&D / treating physician / VP Strategy & Marketing / /
Microsoft Word - Rosetta Agreement with TAU FINAL.docx